Companies: 10,795·Total market cap: $144.5T
Geron Corporation

Geron Corporation

GERNNASDAQHealthcare● Active
$1.13
$-0.04(-3.42%)
Market Cap$724918701
P/E Ratio
52W High$2.01
52W Low$1.04

Geron Corporation (GERN) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

gern · stock forecast · 22 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 22 Wall Street analysts in the past 3 months

SellBuy

Buy

22 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
17
Hold
5
Sell
0
Strong Sell
0
Total: 22 · Buy rate: 77.3%

12-Month Price Target

High

$8.00

Consensus

$5.89

+421.2% upside

Low

$4.00

Median: $6 · Last Close: $1.13

The Geron Corporation (GERN) analyst consensus is Buy, based on ratings from 22 Wall Street analysts over the past 3 months. The average 12-month GERN price target is $5.89, representing +421.2% upside from the current price of $1.13.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $6 (421.2%)

Consensus Target

$5.89

421.2% upside

High Target

$8

608.0%

Low Target

$4

254.0%

Current Price

$1.13

as of today

Based on analyst price targets, the GERN stock price prediction for the next 12 months ranges from $4 to $8. The consensus GERN price forecast of $5.89 implies 421.2% upside from the current price of $1.13.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$1.075.00%

1-day model range: $1.07–$1.08. Peak: $1.08 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$1-50.0%
2028$0-63.8%
2029$0-69.2%
2030$0-71.8%
2031-73.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)34.4Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · GERN · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$1.17SELL
MA 10$1.21SELL
MA 20$1.26SELL
MA 50$1.46SELL
MA 100$1.51SELL
MA 200$1.40SELL
Current $GERN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$1.17SELL
EMA 10$1.20SELL
EMA 20$1.27SELL
EMA 50$1.39SELL
EMA 100$1.44SELL
EMA 200$1.52SELL
Current $GERN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Needham2025-11-05
Maintains
BuyBuy
Scotiabank2025-05-08
Downgrade ↓
Sector OutperformSector Perform
HC Wainwright & Co.2025-03-12
Maintains
NeutralNeutral
Needham2025-03-12
Maintains
BuyBuy
Scotiabank2025-02-27
Maintains
Sector OutperformSector Outperform
Stifel2025-02-27
Maintains
BuyBuy
Barclays2025-02-27
Maintains
OverweightOverweight
Needham2025-02-27
Maintains
BuyBuy
HC Wainwright & Co.2025-02-26
Downgrade ↓
BuyNeutral
B. Riley Securities2025-02-18
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Geron Corporation (GERN) stock. Of the recent 84 rating actions, 10 were upgrades and 8 were downgrades. 22 analysts currently cover GERN.

Analyst Recommendation Trends

Buy ratings211
Hold ratings00
Sell ratings00

GERN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$234M

↓ 51.9% YoY

Revenue Next Year

$333M

↑ 42.5% YoY

EPS This Year

$-0.02

EPS Next Year

$0.07

↓ 378.6% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast GERN EPS of $-0.02 for the current fiscal year, based on estimates from 5 analysts. The GERN revenue forecast is $234M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The GERN stock forecast is supported by two independent data sources: analyst consensus ratings from 22 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus GERN price target is $5.89 (+421.2% upside), with an analyst consensus of Buy.

The GERN short-term stock prediction for tomorrow is $1.07 (-5.00%). The GERN stock price prediction for 2027 estimates an average of $1. The GERN stock prediction for 2030 projects a range of $0–$0.

Geron Corporation trades on NASDAQ under the ticker GERN. The GERN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 77% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

GERN forecast · 8 questions

According to 22 Wall Street analysts, the average 12-month GERN price target is $5.89, with a high forecast of $8.00 and a low of $4.00. The median price target is shown in the chart above when available. This implies +421.2% potential upside from the current price of $1.13.

GERN price targetWhat is GERN price targetGERN analyst price targetGERN 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.